Dr. Raghava Gollapudi
Claim this profileSan Diego Cardiac Center
Studies Stroke
Studies Heart Valve Disease
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Raghava Gollapudi is currently running
AMPLATZER PFO Occluder
for Patent Foramen Ovale
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.
Recruiting1 award N/A1 criteria
Tendyne Transcatheter Mitral Valve System
for Mitral Regurgitation
Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
Recruiting1 award N/A4 criteria
More about Raghava Gollapudi
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Raghava Gollapudi has experience with
- Tendyne Mitral Valve System
- MitraClip System
- Firehawk Stent
- 2nd Generation DES (XIENCE Family, Promus Family, Resolute/Onyx Family/Endeavor, And Orsiro Stent)
- AMPLATZER™ PFO Occluder
Breakdown of trials Raghava Gollapudi has run
Heart Valve Disease
Valvular Heart Disease
Cardiovascular Disease
Mitral Valve Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raghava Gollapudi specialize in?
Raghava Gollapudi focuses on Stroke and Heart Valve Disease. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Raghava Gollapudi currently recruiting for clinical trials?
Yes, Raghava Gollapudi is currently recruiting for 2 clinical trials in San Diego California. If you're interested in participating, you should apply.
Are there any treatments that Raghava Gollapudi has studied deeply?
Yes, Raghava Gollapudi has studied treatments such as Tendyne Mitral Valve System, MitraClip System, Firehawk Stent.
What is the best way to schedule an appointment with Raghava Gollapudi?
Apply for one of the trials that Raghava Gollapudi is conducting.
What is the office address of Raghava Gollapudi?
The office of Raghava Gollapudi is located at: San Diego Cardiac Center, San Diego, California 92123 United States. This is the address for their practice at the San Diego Cardiac Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.